No Detail Found!

Age-Independent Molecular Resistance Patterns in Tuberculosis Patients: A Cross-Sectional Analytical Study

Author(s)
Harshitha J. Naik Department of Microbiology, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
G. Bhuvaneshwari Department of Microbiology, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
Veena Krishnamurthy Sri Siddhartha Institute of Medical Sciences and Research Centre, India
Nanda Kumar State TB Training and Demonstration Centre, Intermediate Reference Laboratory, Bengaluru, India
Abstract
Background: Tuberculosis (TB) remains a major global public health challenge and further complicated by the emergence of drug-resistant strains. Age may influence drug-resistance patterns due to differences in prior treatment exposure among adults, reactivation of latent infection in the elderly, and ongoing transmission dynamics in younger populations. Objective: To evaluate age-wise differences in the distribution of resistance-associated genetic markers-rpoB, katG, inhA, gyrA, gyrB, rrs, and eis-among bacteriologically confirmed tuberculosis patients. Methods: A laboratory-based cross-sectional analytical study was conducted among 317 confirmed TB patients referred for molecular drug susceptibility testing between January and December 2024. Patients were stratified into four age groups (=17, 18-40, 41-60, and =61 years). Genomic DNA extracted from clinical specimens was analyzed using GenoType MTBDRplus Version 2.0 and MTBDRsl Version 2.0 line probe assays. Age-wise distributions of wild-type (WT) and mutant (MUT) probes were compared using the Chi-square test. Results: Across all age groups, WT probes were predominated for all resistance-associated genes analyzed. No statistically significant association was observed between age and most molecular resistance markers (p>0.05). A significant age-wise association was identified only for rpoB MUT1 p = 0.022, with higher mutation frequency among patients aged 18-40 years and =61 years. Mutations associated with isoniazid, fluoroquinolone, and injectable drug resistance did not vary significantly across age categories. Conclusion: Age was not a major determinant of molecular drug resistance patterns in tuberculosis patients, except for rpoB MUT1. These findings indicate that molecular drug susceptibility testing should be applied uniformly across all age groups, and diagnostic decisions should not be influenced by patient age alone. Larger, multicentric age-stratified studies are warranted to detect subtle epidemiological trends in drug-resistant TB.
Publication Details
Page(s) 96-104
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 2, Year: 2026

Request the full text from PASTIC

Keywords
inhA, Age Analysis, rpoB, Line Probe Assay, Molecular Drug Resistance, Tuberculosis, katG
References
.2023 .. Global tuberculosis report, : .
Lange C. .2019 .Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. , 394(10202) : 953-966.
Dheda K. .2017 .The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrugresistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory Medicine vol. 5 no. 4, : 291-360.
Telenti A. .1993 .Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. , 341(8846) : 647-650.
Deun Van,A. Van .2009 .Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. ” Journal of Clinical, 47(11) : 3501-3506.
Zhang Y.,Yew Y. .2015 .Mechanisms of drug resistance in Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung, 19(11) : 1276-1289.
Ramaswamy S.,Musser J.M. “ . .Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis. ” Tuberculosis and Lung, 79(1) : 3-29.
Somoskoví A. . .Diagnostic implications of Mycobacterium tuberculosis complex line probe assays. ” Clinical Microbiology Reviews, 26(3) : 421-439.
Cambau E. .2016 .Revisiting susceptibility testing in MDRTB.” Clinical Microbiology and. , 22(11) : 971-980.
Sandgren A. .2009 .Tuberculosis drug resistance mutation database. PLoS Medicine vol. 6 no. 2, : e1000002.
.2016 .The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin. , : .
Lawn S.D.,Zumla A.I. .2011 .. , 378(9785) : 57-72.
Fox G.J. .2017 .Preventing the spread of multidrug-resistant tuberculosis in children.” The Lancet Infectious Diseases vol. , 17(12) : e293-e302.
Dean A.S. .2014 .Epidemiology of drug-resistant tuberculosis. International Journal of Tuberculosis and Lung, 18(12) : 1436-1442.
Cegielski J.P. . .Extensively drug-resistant tuberculosis. ” Clinical Infectious Diseases, 59(5) : 728-735.
Nathavitharana R.R. . .Accuracy of molecular diagnostics for TB.” Clinics in Chest Medicine vol. , 40(4) : 703-719.
Lifescience GmbH. “GenoType MTBDRplus VER Hain .2016 .2.0: instructions for use. , : .
Lifescience GmbH. “GenoType MTBDRsl VER Hain .2016 .2.0: instructions for use. , : .
Altman D.G .1991 .. , : .
Rosner B. .2015 .Fundamentals of Biostatistics. , : .
“ . .. ” MSD Manual Professional Edition., : .
Mohanty P.S. . .Host factors in leprosy epidemiology: high leprosy among children and adults aged 20-30 years in endemic regions. , : .
de Oliveira A.L. . .Leprosy among children under 15 years of age: literature review; children aged 10-14 years show active disease and ongoing transmission. , : .
Mahajan N. . .Evidence for Mycobacterium leprae drug resistance in a large cohort of leprous neuropathy patients from India. American Journal of Tropical Medicine and Hygiene, 102(3) : 547-552.
Pereira A.L. . .Leprosy: clinical and epidemiological study in patients above 60 years in Espírito Santo State, Brazil; most cases between 61-80 years, with male predominance and multibacillary forms. , : .
. .Age related rate of antimicrobial resistance in clinical isolates. ” BMC, 23 : .
Zignol M. .2018 .Surveillance of anti-tuberculosis drug resistance. ” Emerging Infectious, 24(12) : 230-238.
Central TB,Division. “National Tuberculosis Elimination TB .2023 .Programme (NTEP) guidelines. Ministry of Health and Family Welfare, : .
0

Citations

0

Downloads

14

Views